Ian Rabinowitz MD

Oncology•Albuquerque, NM

Professor, Internal Medicine, University of New Mexico School of Medicine

Join to View Full Profile

UNM Cancer Ctr1201 Camino de Salud NEAlbuquerque, NM 87131
Phone+1 505-272-4946
Fax+1 505-925-0100

Education & Training

Washington University/B-JH/SLCH ConsortiumFellowship, Hematology and Medical Oncology, 1989 - 1992
Vanderbilt University Medical CenterResidency, Internal Medicine, 1986 - 1989
University of the WitwatersrandClass of 1984

Certifications & Licensure

NM State Medical License 1997 - 2025
TN State Medical License 1989 - 1992
American Board of Internal Medicine Internal Medicine

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification MOSAIQ EMR, Elekta, 2014

Clinical Trials

Zoledronate in Preventing Skeletal (Bone)-Related Events in Men Who Are Receiving Androgen Deprivation Therapy For Prostate Cancer and Bone Metastases Start of enrollment: 2004 Jan 01
Completed
Phase 3
Flavopiridol, Gemcitabine, and Irinotecan in Treating Patients With Unresectable or Metastatic Solid Tumors Start of enrollment: 2004 Apr 01
Completed
Phase 1
Gene Expression Analysis of Patients With Metastatic Colorectal Cancer Receiving Oxaliplatin Based Chemotherapy Regimen Start of enrollment: 2004 Apr 01
Completed
Not Applicable
A Phase II Study of Gleevec and Arsenic Trioxide in Patients With CML Who Fail Gleevec Start of enrollment: 2004 Apr 01
Completed
Phase 2
Trial of Thalidomide, a- Interferon +/- Octreotide in Patients With Unresectable Hepatocellular Carcinoma Start of enrollment: 2000 Sep 01
Completed
Phase 2
INST Phase II Trial of Gemcitabine and Irinotecan in Patients With Relapsed or Refractory Lymphoma. Start of enrollment: 2002 Aug 01
Completed
Phase 2
Physiological Biomarkers of Cancer Treatment Related Fatigue in Women With Breast Cancer. Start of enrollment: 1999 Feb 01
Terminated
A Phase III Randomized Trial Assessing the Utility of a Test Dose Program With Taxanes Start of enrollment: 2002 Jun 01
Completed
Phase 3
Dysregulated Tyrosine Kinase Signaling in Leukemia Start of enrollment: 2002 May 01
Terminated
Phase I-II Study of Carboplatin, Vinorelbine and Capecitabine in Patients With Metastatic Breast Cancer Start of enrollment: 2000 May 01
Completed
Phase 1, Phase 2
Prostate Radiation Therapy or Short-Term Androgen Deprivation Therapy and Pelvic Lymph Node Radiation Therapy With or Without Prostate Radiation Therapy in Treating Patients With a Rising Prostate Specific Antigen (PSA) After Surgery for Prostate Cancer
ACTIVE_NOT_RECRUITING
PHASE3
Biomarker Study of Neoadjuvant Vitamin E in Patients With Locally Treatable Prostate Cancer Start of enrollment: 2008 Sep 01
Terminated
Phase 3
A Study of Imatinib and Valproic Acid in Patients With Chronic Myelogenous Leukemia (CML) Start of enrollment: 2009 Sep 01
Withdrawn
Phase 2
Phase I Trial of Everolimus, Pomalidomide and Dexamethasone in Patients With Relapsed/Refractory Multiple Myeloma Start of enrollment: 2014 Jul 01
Terminated
Phase 1
Compassionate Use of BYL 719 Alpelisib
No longer available
Join now to see all

Publications & Presentations

PubMed

1 citations
The Equipoise Between the Treatment of Glioblastoma and the Risk of Secondary Acute Myelogenous Leukemia: An Illustrative Case Report.
Moises Harari-Turquie, Krishna Rekha Moturi, Darrell D Horton, Ian Rabinowitz
Journal of Investigative Medicine High Impact Case Reports. 2023-08-19
3 citations
The inflammatory response of human pancreatic cancer samples compared to normal controls.
Kathryn J Brayer, Joshua A Hanson, Shashank Cingam, Cathleen Martinez, Scott A Ness
Plos One. 2023-01-01
9 citations
Genomic landscape of lymphatic malformations: a case series and response to the PI3Kα inhibitor alpelisib in an-of-1 clinical trial.
Montaser F Shaheen, Julie Y Tse, Ethan S Sokol, Margaret Masterson, Pranshu Bansal
Elife. 2022-07-05

Press Mentions

Reader Responses: Should a Pregnant Patient with Hemochromatosis Receive Iron?September 1st, 2020
Colorectal Cancer Awareness MonthMarch 19th, 2018

Professional Memberships

American Society of Clinical Oncology - ASCO
Member

Ian Rabinowitz MD

Dr. Rabinowitz is on Doximity

Education & Training

Certifications & Licensure

Awards, Honors, & Recognition

Clinical Trials

Publications & Presentations

Press Mentions

Professional Memberships

Viewing the full profile is available to verified healthcare professionals only.